van Houdt IS - Search Results

1

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.

van Houdt IS, Sluijter BJ, Moesbergen LM, Vos WM, de Gruijl TD, Molenkamp BG, van den Eertwegh AJ, Hooijberg E, van Leeuwen PA, Meijer CJ, Oudejans JJ. van Houdt IS, et al. Int J Cancer. 2008 Aug 1;123(3):609-15. doi: 10.1002/ijc.23543. Int J Cancer. 2008. PMID: 18498132 Free article.

2

Absence of Granzyme B positive tumour-infiltrating lymphocytes in primary melanoma excisional biopsies is strongly associated with the presence of sentinel lymph node metastasis.

van Houdt IS, Sluijter BJ, van Leeuwen PA, Moesbergen LM, Hooijberg E, Meijer CJ, de Gruijl TD, Oudejans JJ, Boven E. van Houdt IS, et al. Cell Oncol. 2009;31(5):407-13. doi: 10.3233/CLO-2009-0485. Cell Oncol. 2009. PMID: 19759420 Free PMC article.

3

Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma.

van Houdt IS, Oudejans JJ, van den Eertwegh AJ, Baars A, Vos W, Bladergroen BA, Rimoldi D, Muris JJ, Hooijberg E, Gundy CM, Meijer CJ, Kummer JA. van Houdt IS, et al. Clin Cancer Res. 2005 Sep 1;11(17):6400-7. doi: 10.1158/1078-0432.CCR-05-0306. Clin Cancer Res. 2005. PMID: 16144945

4

Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.

Muris JJ, Cillessen SA, Vos W, van Houdt IS, Kummer JA, van Krieken JH, Jiwa NM, Jansen PM, Kluin-Nelemans HC, Ossenkoppele GJ, Gundy C, Meijer CJ, Oudejans JJ. Muris JJ, et al. Among authors: van houdt is. Blood. 2005 Apr 1;105(7):2916-23. doi: 10.1182/blood-2004-07-2716. Epub 2004 Dec 2. Blood. 2005. PMID: 15576477 Free article. Clinical Trial.

5

Expression of c-FLIP is primarily detected in diffuse large B-cell lymphoma and Hodgkin's lymphoma and correlates with lack of caspase 8 activation.

van Houdt IS, Muris JJ, Hesselink AT, Kramer D, Cillessen SA, Moesbergen LM, Vos W, Hooijberg E, Meijer CJ, Kummer JA, Oudejans JJ. van Houdt IS, et al. Histopathology. 2007 Dec;51(6):778-84. doi: 10.1111/j.1365-2559.2007.02882.x. Histopathology. 2007. PMID: 18042067

6

Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with beta-tryptase monomers.

Strik MC, Wolbink A, Wouters D, Bladergroen BA, Verlaan AR, van Houdt IS, Hijlkema S, Hack CE, Kummer JA. Strik MC, et al. Among authors: van houdt is. Blood. 2004 Apr 1;103(7):2710-7. doi: 10.1182/blood-2003-08-2981. Epub 2003 Dec 11. Blood. 2004. PMID: 14670919 Free article.

7

Tetraspanin CD37 protects against the development of B cell lymphoma.

de Winde CM, Veenbergen S, Young KH, Xu-Monette ZY, Wang XX, Xia Y, Jabbar KJ, van den Brand M, van der Schaaf A, Elfrink S, van Houdt IS, Gijbels MJ, van de Loo FA, Bennink MB, Hebeda KM, Groenen PJ, van Krieken JH, Figdor CG, van Spriel AB. de Winde CM, et al. Among authors: van houdt is. J Clin Invest. 2016 Feb;126(2):653-66. doi: 10.1172/JCI81041. Epub 2016 Jan 19. J Clin Invest. 2016. PMID: 26784544 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7 results

Search Page